ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
4 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
474
|
151K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
7 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
474
|
151K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
8 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
474
|
151K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
251K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
670
|
251K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
251K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
670
|
251K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
2x2 Yay Or Nay From The FDA?
|
|
Babbanap
|
13 |
4.4K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
13
|
4.4K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
474
|
151K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Babbanap
|
46 |
15K |
4 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
15K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
474
|
151K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
12 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
474
|
151K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Babbanap
|
46 |
15K |
11 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
15K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Babbanap
|
46 |
15K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
15K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Babbanap
|
46 |
15K |
16 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
15K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Babbanap
|
46 |
15K |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
15K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
474
|
151K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Babbanap
|
46 |
15K |
8 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
15K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
11 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
474
|
151K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
5 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
474
|
151K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
8 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
474
|
151K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
474
|
151K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
474
|
151K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
7 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
474
|
151K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
474
|
151K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
474
|
151K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
474
|
151K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
28 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
474
|
151K
|
28
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
21 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
474
|
151K
|
21
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
474
|
151K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
9 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
474
|
151K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
251K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
670
|
251K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
251K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
670
|
251K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
0 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
474
|
151K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
251K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
670
|
251K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
474
|
151K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Babbanap
|
474 |
151K |
5 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
474
|
151K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
251K |
0 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
670
|
251K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
251K |
4 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
670
|
251K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
251K |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
670
|
251K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
The PR
|
|
Babbanap
|
6 |
3.0K |
4 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
6
|
3.0K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
The PR
|
|
Babbanap
|
6 |
3.0K |
28 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
6
|
3.0K
|
28
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
Babbanap
|
54 |
17K |
3 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
54
|
17K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
Babbanap
|
54 |
17K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
54
|
17K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
Babbanap
|
54 |
17K |
5 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
54
|
17K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
251K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
670
|
251K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
251K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
670
|
251K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
251K |
7 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
670
|
251K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Babbanap
|
670 |
251K |
18 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
670
|
251K
|
18
|
|
ASX - By Stock
|
PAR |
Re:
IPPS and the most important membrane
|
|
Babbanap
|
19 |
7.9K |
10 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
19
|
7.9K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
IPPS and the most important membrane
|
|
Babbanap
|
19 |
7.9K |
32 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
19
|
7.9K
|
32
|
|
ASX - By Stock
|
PAR |
Re:
IPPS and the most important membrane
|
|
Babbanap
|
19 |
7.9K |
5 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
19
|
7.9K
|
5
|
|